News

  1. You are here:
  2. Start
  3. Department of Biochemistry and Biophysics
  4. About us
  5. News
  6. A new Botulinum Neurotoxin discovered

A new Botulinum Neurotoxin discovered

The first new Botulinum Neurotoxin in almost half a century has been discovered by researchers at Stockholm University and Harvard Medical School. Botulinum toxins are widely used to treat a growing list of medical conditions. The article has been published in Nature Communications.

Structure of the first botulinum neurotoxin (BoNT/A) discovered in 1897. Credits: Pål Stenmark
Structure of the first botulinum neurotoxin (BoNT/A) discovered in 1897. Credits: Pål Stenmark

 

Botulinum toxins are currently used on more than 80 medical conditions including Muscle spasms, Overactive bladder, Chronic migraine, Cervical dystonia, Sweating and Cerebral Palsy (CP). The new toxin, Botulinum neurotoxin type X (BoNT/X), has the potential to open up a new field of toxin therapeutics related to intracellular membrane trafficking and secretion.

Since Botulinum neurotoxins are the most toxic substances known, the development of detection methods and treatments is very important.

“The discovery of BoNT/X facilitates the development of diagnostics and countermeasures which is important if someone would be exposed to a toxic amount of the substance”, says Pål Stenmark, Associate Professor, Department of Biochemistry and Biophysics, Stockholm University.

The research team will now develop antibodies with the ability to detect and inactivate the toxin.

“Within a few months we will have developed ways of detecting if a person has been subject to BoNT/X”, says Pål Stenmark.

The researchers will determine the structure of the toxin and investigate how it binds to the nerve cell. They will also investigate how the unique properties of BoNT/X can be best used to develop new therapeutics.

Discovered through an infant in Japan
It all started with an infant in Japan that became ill in 1995. In 2015 the genome of the bacteria isolated from the child was sequenced and deposited in a database. Hidden in the four million letter blueprint of the bacterium, the research team identified the novel toxin.

“When we first discovered this toxin I believed we had made some error in the analysis, but after checking several times it turned out to be correct. This discovery opens a multitude of new exciting research topics that we are eager to explore in collaboration with Dr. Min Dong’s research team at Harvard”, says Pål Stenmark.

The article “Identification and characterization of a novel botulinum neurotoxin” is published in the scientific journal Nature Communications.

Bookmark and share Tell a friend

Contacts

Postal Address
Department of Biochemistry and Biophysics
Stockholm University
Svante Arrhenius väg 16C
SE-106 91 Stockholm
Sweden

Visiting Address
Svante Arrhenius väg 16C

Billing Address
Non-Swedish companies: use postal address
Stockholm University
Postbox 50741
SE-202 70 Malmö

Head of Department
Lena Mäler
+46 8 16 2448/work mobile 073 2704359
lena.maler@dbb.su.se

Vice Head of Department
Gunnar von Heijne
+46 8 16 2590
gunnar.heijne@dbb.su.se

Head of Administration
Ann Nielsen
+46 8 16 2594
ann.nielsen@dbb.su.se

Director of Bachelor's Studies
Pia Harryson
+46 8 16 4238
pia.harryson@dbb.su.se

Director of Master's Studies
Andreas Barth
+46 8 16 2452
andreas.barth@dbb.su.se

Director of Doctoral Studies
Pia Ädelroth
+46 8 16 4183
pia.adelroth@dbb.su.se

Alumni info